C
Contineum Therapeutics, Inc. (CTNM)
NMS – Real Time Price. Currency in USD
13.34
-0.31 (-2.27%)
At close: Mar 27, 2026, 4:00 PM EDT
13.34
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
NMS – Real Time Price. Currency in USD
13.34
-0.31 (-2.27%)
At close: Mar 27, 2026, 4:00 PM EDT
13.34
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:00 PM EDT
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company’s lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and chronic pain. It also develops PIPE-307, a novel, small-molecule inhibitor of the muscarinic type 1 receptor for depression and relapse-remitting multiple sclerosis. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is based in San Diego, California.
| Name | Position |
|---|---|
| Dr. Daniel S. Lorrain Ph.D. | Chief Science Officer |
| Dr. Timothy R. Watkins M.D., M.Sc. | Chief Medical Officer & Head of Development |
| Mr. Austin Chen Ph.D. | Senior VP & Head of Research |
| Mr. Carmine N. Stengone MBA, MS | President, CEO & Director |
| Mr. John S. Healy | General Counsel & Corporate Secretary |
| Mr. Peter T. Slover CPA | Chief Financial Officer |
| Mr. Steve E. Kunszabo | Senior Director of Investor Relations & Corporate Communications |
| Date | Type | Document |
|---|---|---|
| 2026-03-05 | S-8 | a2026s-8.htm |
| 2026-01-26 | 8-K | ctnm20260121_8k.htm |
| 2025-12-15 | 8-K | ctnm20251214_8k.htm |
| 2025-12-11 | 8-K | ctnm20251204_8k.htm |
| 2025-11-20 | 8-K | ctnm20251117_8k.htm |
| 2025-10-30 | 8-K | ctnm20251015_8k.htm |
| 2025-09-18 | 8-K | ctnm20250910_8k.htm |
| 2025-08-05 | 8-K | ctnm20250616_8k.htm |
| 2025-06-26 | 8-K | ctnm20250616c_8k.htm |
| 2025-05-21 | CORRESP | filename1.htm |
| Ms. Jennifer Patterson |
| Vice President of Human Resources |
| Ms. Julie S. Iwashita | Senior Vice President of Clinical Operations |
| Ms. Morgan Paulsen | Senior Manager of Accounting |